EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Machbarkeit und vorläufige Wirksamkeit von aerobem Akuttraining vor Immuntherapie- und Chemotherapie-Infusion bei Patient:innen mit metastasiertem nicht-kleinzelligem Lungenkarzinom: randomisierte kontrollierte Studie

Manon Gouez iD, Olivia Pérol iD, Vincent Pialoux iD, Virginie Avrillon iD, Maxime Boussageon, Chantal Decroisette, Lidia Delrieu iD, Houssein El Hajj iD, Baptiste Fournier iD, Romane Gille iD, Mathilde His iD, Bénédicte Mastroianni iD und 3 weitere

Journal of Clinical Medicine · 01.01.2026 · 15 (1) · 334

DOI: 10.3390/jcm15010334 ↗

Auf einen Blick

Bei 26 Patient:innen mit mNSCLC war Akuttraining vor jeder ICT machbar und sicher. Hinweise aus Selbstberichten sprechen für günstigere Fitness-, Müdigkeits- und Schlafwerte.

Fragestellung

Ist aerobes Akuttraining direkt vor jeder ICT-Gabe bei mNSCLC machbar und mit Ergebnissen zu Fitness und patientenberichteten Outcomes verbunden?

Methode

Randomisierte kontrollierte Studie; neu diagnostizierte mNSCLC-Patient:innen, 2:1 zu Training oder Kontrolle; 4 ICT-Zyklen plus 3 Monate Home-Walking-Programm; Bewertung nach 3 Monaten.

Ergebnisse

26 Patient:innen; 87,5 % Akzeptanz. In der Trainingsgruppe (n = 17) absolvierten 80,9 % die Akutsitzungen; median 38 min [IQR 20–60] zwischen Training und ICT. Keine trainingsbedingten unerwünschten Ereignisse.

Einschränkungen

Vorläufige Ergebnisse; kleine Stichprobe; explorative Outcomes zu Fitness und patientenberichteten Endpunkten.

Schlussfolgerung der Autor:innen

Akuttraining unmittelbar vor jeder ICT-Gabe bei Patient:innen mit mNSCLC erscheint machbar und sicher.

Kernaussagen

  • 87,5 % akzeptierten die Studie
  • 80,9 % der Trainingsgruppe absolvierten die Akutsitzungen
  • Keine trainingsbedingten unerwünschten Ereignisse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.01.2026. Verfasst von Manon Gouez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention and Environment, Léon Bérard Cancer Center, 69008 Lyon, France. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Ministry of Education, Research and Innovation.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Recent preclinical studies suggest that acute exercise induces immune modulation, enhances tumor blood perfusion, and is associated with reduced tumor growth. Adding exercise to immunochemotherapy treatment (ICT) has been proposed as a strategy to increase treatment effectiveness. The ERICA trial (NCT04676009) aimed to assess the feasibility of acute aerobic exercise performed immediately before the administration of ICT in patients with metastatic non-small cell lung cancer (mNSCLC) and to explore hypothesis-generating outcomes related to physical fitness and patient-reported outcomes.

Methods

Newly diagnosed mNSCLC patients were randomly assigned (2:1) to the exercise or control group. The exercise intervention included supervised acute exercise before each of four ICT cycles plus a 3-month home-based walking program with an activity tracker and step goals. The feasibility of the exercise protocol was assessed through adherence, acceptability, tolerability, and safety. Clinical, physical, and patient-reported outcomes were assessed at baseline and after 3 months.

Results

Twenty-six patients (mean age 60.6 years; SD 10.65) participated, with an 87.5% acceptance rate. In the exercise group (n = 17), 80.9% of participants completed the acute exercise sessions, with a median interval of 38 min [IQR, 20–60] between exercise and ICT. No exercise-related adverse effects were reported. After 3 months, 60% of participants in the exercise group were classified as active and maintained their step goals. Self-reported measures suggest that maintaining physical fitness is favorable for reducing fatigue and insomnia, and therefore improving quality of life.

Conclusions

Acute exercise performed immediately before each ICT administration in patients with mNSCLC appears feasible and safe.

Schlagwörter

Stichwörter der Autor:innen

exerciseimmune systemimmunotherapylung cancermetastatic

Autor:innen und Institutionen

  • Department of Cancer Prevention and Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
  • Inter-University Laboratory of Human Movement Biology EA7424, University Claude Bernard Lyon 1, University of Lyon, 69622 Villeurbanne, France.
  • 1296 Unit Radiations: Defense, Institut National de la Santé et de la Recherche Médicale (INSERM), Health and Environnement, Lyon, France.
  • Department of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France.
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.
  • IRMES, Institute for Research in Biomedicine and Epidemiology of Sport, UPR7329, Université Paris Cité, Paris, France.

ORCID-Profile: Manon Gouez, Olivia Pérol, Vincent Pialoux, Virginie Avrillon, Lidia Delrieu, Houssein El Hajj, Baptiste Fournier, Romane Gille, Mathilde His, Bénédicte Mastroianni, Aurélie Swalduz, Maurice Pérol, Béatrice Fervers

Förderung

  • French Ministry of Education, Research and Innovation

Zitieren

APA

Gouez, M., Pérol, O., Pialoux, V., Avrillon, V., Boussageon, M., Decroisette, C., Delrieu, L., El Hajj, H., Fournier, B., Gille, R., His, M., Mastroianni, B., Swalduz, A., Pérol, M., & Fervers, B. (2026). Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial. Journal of Clinical Medicine, 15(1), 334. https://doi.org/10.3390/jcm15010334

Vancouver

Gouez M, Pérol O, Pialoux V, Avrillon V, Boussageon M, Decroisette C, et al. Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial. Journal of Clinical Medicine. 2026;15(1):334. doi:10.3390/jcm15010334

BibTeX
@article{Gouez2026,
  author = {Gouez, Manon and Pérol, Olivia and Pialoux, Vincent and Avrillon, Virginie and Boussageon, Maxime and Decroisette, Chantal and Delrieu, Lidia and El Hajj, Houssein and Fournier, Baptiste and Gille, Romane and His, Mathilde and Mastroianni, Bénédicte and Swalduz, Aurélie and Pérol, Maurice and Fervers, Béatrice},
  title = {Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {334},
  doi = {10.3390/jcm15010334}
}
Kostenlos starten →